- Generic name
- Sacubitril + Valsartan
- Strength
- 49 mg + 51 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Sacuva 100 Tablet
About Sacuva 100 49 mg + 51 mg Tablet
Sacuva 100 49 mg + 51 mg is a tablet product of The ACME Laboratories Ltd. that contains Sacubitril + Valsartan. It is also used for symptomatic heart failure with left ventricular systolic dysfunction in children aged one year and older.
There are 25 brands of Sacubitril + Valsartan listed in Bangladesh. The lowest listed price is Arnis 24 mg+26 mg Tablet at ৳ 35.00 per unit.
What is Sacuva 100 49 mg + 51 mg Tablet?
Made by The ACME Laboratories Ltd., Sacuva 100 is a tablet whose active ingredient is Sacubitril + Valsartan. It contains two active substances, sacubitril and valsartan, in a strength of 49 mg + 51 mg. This combination belongs to a group of heart failure medicines. Whether it suits you is a decision for your doctor.
Uses of Sacuva 100
It is also used for symptomatic heart failure with left ventricular systolic dysfunction in children aged one year and older. Sacuva 100 is used in adults with chronic heart failure and reduced ejection fraction to lower the risk of cardiovascular death and hospitalisation for heart failure. It helps lower the risk of dying from heart problems and reduces the chance of needing hospital care for heart failure. The doctor decides whether it is suitable and the dose and course.
How to use Sacuva 100
Swallow the tablet with water. Sacuva 100 is taken by mouth. Keep the medicine out of reach of children. The dose and how often you take it will be decided by your doctor based on your condition and other medicines you take. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling the next one.
Side effects of Sacuva 100
Side effects that need attention include swelling of the face, lips, tongue or throat (angioedema), low blood pressure with dizziness or fainting, worsening kidney function, raised potassium, cough and dizziness. Do not ignore severe symptoms. Tell your doctor straight away if you have trouble breathing, swelling, or feel very dizzy or faint. Tell your doctor if you notice any side effects or if they bother you.
Safety and precautions
Sacuva 100 must not be used if you have had angioedema related to an ACE inhibitor or ARB, or if you have hereditary angioedema. Before starting, tell your doctor about any kidney or liver problems, low blood pressure, or high potassium. Women who can become pregnant should use effective contraception and tell their doctor if they become pregnant. Tell your doctor about all medicines you take, including NSAIDs, potassium-sparing diuretics and lithium.
Frequently asked questions
What does Sacuva 100 treat?
It is also used for symptomatic heart failure with left ventricular systolic dysfunction in children aged one year and older. Sacuva 100 is used in adults with chronic heart failure and reduced ejection fraction to lower the risk of cardiovascular death and hospitalisation for heart failure.
How is Sacuva 100 used?
Swallow the tablet with water. Sacuva 100 is taken by mouth.
What are the side effects of Sacuva 100?
Side effects that need attention include swelling of the face, lips, tongue or throat (angioedema), low blood pressure with dizziness or fainting, worsening kidney function, raised potassium, cough and dizziness. Do not ignore severe symptoms.
Can I use Sacuva 100 in pregnancy or while breastfeeding?
Sacuva 100 must not be used if you have had angioedema related to an ACE inhibitor or ARB, or if you have hereditary angioedema. Before starting, tell your doctor about any kidney or liver problems, low blood pressure, or high potassium.
Indications
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. ... Read more
- To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class ll-IV) and reduced ejection fraction.
- For the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older.
- This is usually administered in conjunction with other heart failure therapies, in place of an angiotensin-converting enzyme inhibitor (ACEi) or other ARB.
Pharmacology
Dosage & Administration
Reduce the starting dose to 24/26 mg twice daily for:
- Patients not currently taking an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) or previously taking a low dose of these agents.
- Patients with severe renal impairment.
- Patients with moderate hepatic impairment.
Recommended Dose Titration-
Pediatric Patients Less than 40 kg:
- Starting: 1.6 mg/kg
- Second: 2.3 mg/kg
- Final: 3.1 mg/kg
- Starting: 24/26 mg
- Second: 49/51 mg
- Final: 49/51 mg
- Starting: 49/51 mg
- Second: 72/78 mg
- Final: 97/103 mg
Interaction
Potassium-sparing Diuretics: Serum potassium level may be increased.
NSAIDs: Risk of renal impairment may be increased.
Lithium: Increased risk of lithium toxicity.
Contraindications
- In patients with hypersensitivity to any component
- In patients with a history of angioedema related to previous ACE inhibitor or ARB therapy
- With concomitant use of ACE inhibitors. Do not administer within 36 hours of switching from or to an ACE inhibitor
- With concomitant use of aliskiren in patients with diabetes
Side Effects
Pregnancy & Lactation
Geriatric Use: No relevant pharmacokinetic differences have been observed in elderly (>65 years) or very elderly (>75 years) patients compared to the overall population.
Hepatic Impairment: No dose adjustment is required when administering this tablet to patients with mild hepatic impairment (Child-Pugh A classification). This tablet is not recommended in patients with severe hepatic impairment, as no studies have been conducted in these patients.
Renal Impairment: No dose adjustment is required in patients with mild (eGFR 60 to 90 ml/min/1.73 m2) to moderate (eGFR 30 to 60 ml/min/1.73 m2) renal impairment. The recommended starting dose in patients with severe renal impairment (eGFR <30 ml/min/1.73 m2) is 24/26 mg twice daily.
Precautions & Warnings
This tablet lowers blood pressure and may cause symptomatic hypotension. Closely monitor serum creatinine, and down-titrate or interrupt this tablet in patients who develop a clinically significant decrease in renal function. In patients with renal artery stenosis, monitor renal function.
Monitor serum potassium periodically and treat appropriately, especially in patients with risk factors for hyperkalemia such as severe renal impairment, diabetes, hypoaldosteronism, or a high potassium diet. Dosage reduction or interruption of this tablet may be required.
Overdose Effects
Storage Conditions
Alternative brands of Sacubitril + Valsartan
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.